Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$275K Sell
3,276
-4,383
-57% -$361K 0.33% 87
2025
Q2
$606K Sell
7,659
-520
-6% -$41.3K 0.16% 117
2025
Q1
$734K Sell
8,179
-1,257
-13% -$117K 0.19% 113
2024
Q4
$939K Sell
9,436
-612
-6% -$63.1K 0.24% 81
2024
Q3
$1.14M Buy
10,048
+29
+0.3% +$3.44K 0.29% 68
2024
Q2
$1.24M Buy
10,019
+1,762
+21% +$227K 0.34% 59
2024
Q1
$1.09M Buy
8,257
+130
+2% +$16K 0.31% 64
2023
Q4
$886K Sell
8,127
-234
-3% -$24.3K 0.28% 75
2023
Q3
$861K Buy
8,361
+282
+3% +$30.4K 0.31% 70
2023
Q2
$932K Buy
8,079
+1,485
+23% +$169K 0.35% 67
2023
Q1
$701K Buy
6,594
+392
+6% +$42.3K 0.29% 78
2022
Q4
$688K Buy
6,202
+272
+5% +$27.8K 0.32% 74
2022
Q3
$510K Sell
5,930
-1
-0% -$89 0.25% 98
2022
Q2
$541K Buy
5,931
+291
+5% +$25.8K 0.25% 98
2022
Q1
$463K Buy
+5,640
New +$445K 0.18% 143

Other funds holding MRK

L.M. Kohn & Company's MRK Position: Q3 2025 in Review

L.M. Kohn & Company reduced its Merck (MRK) stake by 57% in Q3 2025, selling an estimated $361K and leaving 3,276 shares worth $275K. The position accounts for 0.33% of the portfolio, ranked #87.

L.M. Kohn & Company first reported a position in MRK in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.24M in Q2 2024. 3,316 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • L.M. Kohn & Company held 3,276 shares of Merck worth $275K as of Q3 2025.
  • L.M. Kohn & Company sold 4,383 Merck shares in Q3 2025, an estimated $361K.
  • Merck made up 0.33% of L.M. Kohn & Company's portfolio in Q3 2025, its #87 holding.
  • L.M. Kohn & Company first reported a position in Merck in Q1 2022 and has held it in 15 quarters since.
  • L.M. Kohn & Company's Merck position peaked at $1.24M in Q2 2024.
  • 3,316 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on L.M. Kohn & Company's 13F filing for Q3 2025, filed 4 Nov 2025.